Position in XWEL
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$6,438
+$3,476 QoQ
Shares Held
6,191
+140.3% QoQ
Ownership
0.072%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 23 holders
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XWEL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CITIGROUP INC holds $1,347,844,187 across 35 Diagnostics & Research names. XWEL ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
650,976 | $326,373,326 | |
| 2 | DHR |
Danaher Corp /De/
|
778,298 | $148,250,202 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
90,754 | $115,939,141 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
165,689 | $87,225,316 | |
| 5 | ILMN |
Illumina, Inc.
|
465,311 | $81,815,632 | |
| 6 | WAT |
Waters Corp /De/
|
213,227 | $79,968,652 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
316,217 | $71,714,852 | |
| 8 | DGX |
Quest Diagnostics Inc
|
315,584 | $66,888,027 |
All Filings in XWEL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,438 | 6,191 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $2,962 | 2,576 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,741 | 8,133 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $11 | 12 | Shares | Defined | 2025-11-10 | |
| 2024-03-31 | $130 | 77 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $620 | 549 | Shares | Defined | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||